Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Immatics N.v. buy BiotechBee

Immatics N.v.
Start price
€10.59
08.09.24 / 60%
Target price
€15.00
31.03.27
Performance (%)
9.35%
End price
€11.58
16.09.24
Summary
This prediction ended on 16.09.24 with a price of €11.58. The BUY prediction by BiotechBee finished with a performance of 9.35%. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Immatics N.v. - - -
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

According to BiotechBee what are the pros and cons of Immatics N.v. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Immatics N.v. diskutieren
Prediction Buy
Perf. (%) 9.35%
Target price 15.000
Change
Ends at 31.03.27

Buy mit Kursziel 15,0

BiotechBee 
0
Report Share
08.09.24
In the thread Trading Immatics N.v.
Prediction Buy
Perf. (%) 9.35%
Target price 15.000
Change
Ends at 31.03.27

Buy beendet

BiotechBee 
0
Report Share
16.09.24

Stopped prediction by BiotechBee for Immatics N.v.

buy
Immatics N.v.

Start price
Target price
Perf. (%)
€11.58
16.09.24
€20.00
31.03.27
-40.03%
14.12.24

Could be very worthwhile Investment >20% year
BiotechBee 
16.09.24 60%
buy
Immatics N.v.

Start price
Target price
Perf. (%)
€13.10
07.09.22
€18.00
31.12.24
-32.14%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
07.09.22 60%